# GENTIBIO, INC.: Engineered Tissue Treg Therapy for the Treatment of ALS

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | GENTIBIO, INC. |
| Location | CAMBRIDGE, MA |
| Project | Engineered Tissue Treg Therapy for the Treatment of ALS |
| Project number | 1R43NS149828-01 |
| Mechanism | R43 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $320,037 |
| Awarded | 2026-09-07 |
| Project period | 2026-09-07 to 2027-08-31 |
| UEI | HNHTFLZ9U5D4 |

## Why this score
- Award of $320,037.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11405442). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.